NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/05/2019
Back to search
Official data from USPTO
INTERNATIONAL PHARMACEUTICAL EXCIPIENTSCOUNCIL IPEC AMERICAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
09/05/2019
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
12/19/1997
Registration date
08/10/1999
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2019
Last transaction
09/05/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/16/1997
First use in commerce
11/16/1997
Drawing code
3
Owner type
03
Owner location
Arlington, VA
Examiner
VAVONESE,DANIEL P
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
I. C. (pessoa física)
Representatives
Jeremy Stroh and John C. Garvey Staas & Halsey LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
association servicespromoting the interests of the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
21 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/05/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/05/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/05/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/24/2009
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/24/2009
PLGL
ASSIGNED TO PARALEGAL
03/16/2009
E89R
TEAS SECTION 8 & 9 RECEIVED
03/12/2009
CFIT
CASE FILE IN TICRS
08/24/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2006
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/17/2004
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
09/30/2004
PAPER RECEIVED
09/30/2004
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/18/2003
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/1999
PUBO
PUBLISHED FOR OPPOSITION
05/18/1999
NPUB
NOTICE OF PUBLICATION
04/16/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/25/1999
CNRT
NON-FINAL ACTION MAILED
10/21/1998
DOCK
ASSIGNED TO EXAMINER
10/13/1998
Continuous trademark protection
Get notified about every new filing that threatens INTERNATIONAL PHARMACEUTICAL EXCIPIENTSCOUNCIL IPEC AMERICAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.